Technology News and Research

RSS

Stereotaxis launches Odyssey Interventional Network portal for global cardiovascular community

Stereotaxis, Inc. announced today that it launched the Odyssey Interventional Network, a training and educational video sharing web portal for the global cardiovascular community. The portal will showcase innovative electrophysiology (EP) and interventional cardiology (IC) procedures from leading centers around the world.

21 Oct 2010

New immunoSEQ bioinformatics software platform helps monitor adaptive immune system

Adaptive TCR Technologies, a biotech firm based in Seattle, WA, announced today the release of its immunoSEQ profiling service and immunoSEQ Analyzer bioinformatics software platform. Together, these tools provide researchers and clinicians the ability to profile and monitor the adaptive immune system at a level of detail that has never before been possible.

21 Oct 2010

Internet searching for health info growing, but not dominant

People still prefer to gather information related to personal health from sources other than the Internet, according to a survey by the Pew Internet Project in association with the California HealthCare Foundation.

21 Oct 2010

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.

21 Oct 2010

Valensa enters agreement with Mercola for Flex Pro ES formulation

Valensa International and Mercola Health Resources, LLC announced today that they have entered into a license and supply agreement that provides Mercola Health Resources with Valensa's new Flex Pro ES(TM) joint health formulation.

21 Oct 2010

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.

21 Oct 2010

Kinemed updates translational biomarkers strategy at 2010 Conference in Boston

Marc K. Hellerstein, M.D., Ph.D. Co-Founder and Chief of SAB, Kinemed, Inc. presented an "Updated Strategy for Using Disease Predictive Translational Biomarkers in the Rapidly Advancing Field of Causal Pathway Measurements" at the 2010 Personalized and Translational Medicine Conference. In Boston, on September 20-21, 2010.

21 Oct 2010

Unitedhealth says it will test lump sum payments for some cancer care, reports earnings

Health insurer UnitedHealth said Tuesday that it will test a new way payment method for cancer doctors. The program pays doctors a lump sum payment for providing care during an entire course of care for the disease instead of how it's done now with a fee for each service a doctor provides.

21 Oct 2010

C PORT Solutions releases new mobile computing platform for healthcare facilities

With the launch of MEDI PORT, C PORT Solutions is the world's first company to converge all forms of communication and collaboration with patient data, medical applications, and existing healthcare technologies so all healthcare professionals can diagnose or treat a patient with the highest level of care regardless of the healthcare professional's location.

21 Oct 2010

NYU Langone Medical Center announces establishment of Smilow Comprehensive Prostate Cancer Center

NYU Langone Medical Center is pleased to announce that it has established The Smilow Comprehensive Prostate Cancer Center with a $5 million gift from Joel E. Smilow, a member of the Board of Trustees at NYU Langone Medical Center and New York University. The Smilow Center is dedicated to providing comprehensive, state-of-the-art personalized care for men with prostate cancer as well as educating men and their families about the disease and the wide range of treatment options available today.

21 Oct 2010

Victorian Government grants assist companies build global markets

The Brumby Labor Government is providing $410,000 in grants to help three Melbourne companies improve their global competitiveness, save money on production costs and create local jobs.

21 Oct 2010

Nexcore announces acquisition of Meditron product line from CooperSurgical

Nexcore Technologies, Inc. of Waldwick, an original equipment manufacturer of medical devices, today announced it has acquired the Meditron line of gastroenterology endoscopy products from CooperSurgical, Inc. of Trumbull, CT.

21 Oct 2010

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak.

21 Oct 2010

Health Impact Project announces $400,000 in grants to 4 organizations to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced nearly $400,000 in grants to four organizations to conduct health impact assessments (HIAs). The assessments will identify and address potential and often overlooked health implications of policy proposals including farm-to-school food legislation, energy development, smart-metering technology for electric utilities and urban transportation plans.

20 Oct 2010

StoneArch Creative receives Gold Award at MM&M 2010

For the third consecutive year, StoneArch Creative was honored with a Gold Award at the 2010 Medical Marketing and Media (MM&M) Awards, held on October 12 in New York City.

20 Oct 2010

Envoy expands drug discovery collaboration with The Scripps Research Institute

Envoy Therapeutics, Inc., a recently-formed drug discovery company, today announced that it has expanded its research collaboration with The Scripps Research Institute aimed at identifying new drugs for neurological and psychiatric diseases.

20 Oct 2010

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

20 Oct 2010

WILD, Sterling Technology announce partnership for Immunel, Tegricel products

WILD Flavors, Inc. is excited to announce a recently formed partnership with Sterling Technology. This new partnership makes WILD the exclusive provider of both Immunel and Tegricel.

20 Oct 2010

BREAKYL drug receives European approval

BioDelivery Sciences International, Inc. and Meda today announced approval of BEMA Fentanyl in Europe via the Decentralized Procedure, with Germany acting as Reference Member State.

20 Oct 2010

Genoptix ranked #41 on Deloitte's Technology Fast 500

Genoptix, Inc., a specialized laboratory services provider, today announced that it ranked number 41 on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the five year period from 2005–2009. Genoptix grew 3,451 percent during this period.

20 Oct 2010

Technology News and Research

Stereotaxis launches Odyssey Interventional Network portal for global cardiovascular community

New immunoSEQ bioinformatics software platform helps monitor adaptive immune system

Internet searching for health info growing, but not dominant

Agensys and Seattle Genetics initiate ASG-5ME phase I clinical trial for castration-resistant prostate cancer

Valensa enters agreement with Mercola for Flex Pro ES formulation

Access submits additional patent applications for Cobalamin-mediated oral drug delivery technology

Kinemed updates translational biomarkers strategy at 2010 Conference in Boston

Unitedhealth says it will test lump sum payments for some cancer care, reports earnings

C PORT Solutions releases new mobile computing platform for healthcare facilities

NYU Langone Medical Center announces establishment of Smilow Comprehensive Prostate Cancer Center

Victorian Government grants assist companies build global markets

Nexcore announces acquisition of Meditron product line from CooperSurgical

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Health Impact Project announces $400,000 in grants to 4 organizations to conduct health impact assessments

StoneArch Creative receives Gold Award at MM&M 2010

Envoy expands drug discovery collaboration with The Scripps Research Institute

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

WILD, Sterling Technology announce partnership for Immunel, Tegricel products

BREAKYL drug receives European approval

Genoptix ranked #41 on Deloitte's Technology Fast 500

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News